Before the opening bell, Singlepoint, Inc. (OTC: SING) kicked off the new year by voicing its support for an ongoing…
Remedies for pain have progressed beyond the one recommended in Shakespeare’s Romeo and Juliet, where the renowned playwright wrote, "One…
In less than a decade, we’ve seen multiple networks spring up that are now connecting hundreds of millions of people.…
With close to half a million sitting in the bank and in short-term securities at the end of the third…
Modern technological advancements are permeating all facets of society and industry and encouraging remote interactions from anywhere and at anytime.…
CytoDyn Inc. (OTCQB: CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus…
There’s a barrage of financial information available at any given moment – while it initially sounds great, investors need a…
In the world of value investing, not all that is gold glitters… like Ohio-based OurPet’s Company, for example. OurPet’s Company…
CytoDyn Inc. (OTCQB: CYDY) is entering a Phase 3 clinical trial with its leading product candidate, PRO 140, and the…
CytoDyn Inc. (OTCQB: CYDY) is a Vancouver, Washington-based biotechnology company engaged in the clinical development and potential commercialization of humanized…